Pemetrexed Monotherapy as Salvage Treatment in Patients with Metastatic Colorectal Cancer Refractory to Standard Chemotherapy: A Phase II Single-arm Prospective Trial

Background: We designed a single-arm, open-label phase II study to determine the efficacy and toxicity of pemetrexed monotherapy with vitamin supplementation in patients with refractory colorectal cancer (CRC) that failed to respond to standard treatments including 5-fluorouracil, oxaliplatin, and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sung Won, Lee, Sujin, Lee, Jeeyun, Park, Se Hoon, Park, Joon Oh, Park, Young Suk, Lim, Ho Yeong, Kang, Won Ki, Kim, Seung Tae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096381/
https://www.ncbi.nlm.nih.gov/pubmed/30123359
http://dx.doi.org/10.7150/jca.24948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6096381/
https://www.ncbi.nlm.nih.gov/pubmed/30123359
http://dx.doi.org/10.7150/jca.24948

Ejemplares similares